Showing results (461-470 of 622) with videos related to

Sort By:
Pageof 63
Science Advances|July 3, 2026
A sustainable seven-electron cascade battery via orchestrated gas-liquid-solid triphase redox reactionsLingchang Wu, Chaoyi Qiu, Junwei Zhang, et al.
Nurse Education in Practice|September 12, 2017
A safety culture training program enhanced the perceptions of patient safety culture of nurse managersJian-Fei Xie, Si-Qing Ding, Zhu-Qing Zhong, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|September 13, 2006
[A randomized control clinical trial of Euruikang (docetaxel) in treatment of advanced non-small cell lung cancer (NSCLC)]Ye Cao, Zhi-Qiang Wang, Ying Guo, et al.
Journal of Biological Engineering|January 4, 2026
Unveiling the mechanism of abdominal and transcranial ultrasound stimulation against DSS-induced colitis based on proteomic analysisFeng-Yi Yang, Meng-Ting Wu, Yi-Ju Pan, et al.
Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chinese Journal of Burns|May 20, 2011
[Screening of differential expression genes of human skin epidermal stem cells at different development stages by cDNA microarray technique]Wei Lan, De-Wu Liu, Guo-Hai Li, et al.
The Review of Scientific Instruments|October 15, 2025
A nanocalorimeter designed for use with high-resolution transmission electron microscopyIzak McGieson, Shane Q Arlington, Lakshmi Ravi Narayan, et al.
Molecular Pharmacology|February 7, 2025
Evaluation of allosteric N-methyl-d-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelingJames S Lotti, Jaron Jones, Jill C Farnsworth, et al.
Molecular Pharmacology|November 5, 2024
Evaluation of allosteric NMDA receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelingJames S Lotti, Jaron Jones, Jill C Farnsworth, et al.
Molecules (Basel, Switzerland)|December 23, 2022
Dihydrochalcones in Sweet Tea: Biosynthesis, Distribution and Neuroprotection FunctionYong-Kang Wang, Si-Yi Hu, Feng-Yi Xiao, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|August 15, 2003
[Phase II clinical trial of oxaliplatin alone for refractory advanced colorectal cancer]Rui-Hua Xu, Zhong-Zhen Guan, Feng-Yi Feng, et al.
Pageof 63